These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 25396123)

  • 1. Melasma update.
    Sarkar R; Arora P; Garg VK; Sonthalia S; Gokhale N
    Indian Dermatol Online J; 2014 Oct; 5(4):426-35. PubMed ID: 25396123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in the treatment of melasma: a review of the recent literature.
    Ball Arefiev KL; Hantash BM
    Dermatol Surg; 2012 Jul; 38(7 Pt 1):971-84. PubMed ID: 22583339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melasma. Etiologic and therapeutic considerations.
    Grimes PE
    Arch Dermatol; 1995 Dec; 131(12):1453-7. PubMed ID: 7492140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tranexamic Acid in the Treatment of Melasma: A Review of the Literature.
    Perper M; Eber AE; Fayne R; Verne SH; Magno RJ; Cervantes J; ALharbi M; ALOmair I; Alfuraih A; Nouri K
    Am J Clin Dermatol; 2017 Jun; 18(3):373-381. PubMed ID: 28283893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interventions for melasma.
    Rajaratnam R; Halpern J; Salim A; Emmett C
    Cochrane Database Syst Rev; 2010 Jul; (7):CD003583. PubMed ID: 20614435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melasma: an Up-to-Date Comprehensive Review.
    Ogbechie-Godec OA; Elbuluk N
    Dermatol Ther (Heidelb); 2017 Sep; 7(3):305-318. PubMed ID: 28726212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of melasma with topical agents, peels and lasers: an evidence-based review.
    Rivas S; Pandya AG
    Am J Clin Dermatol; 2013 Oct; 14(5):359-76. PubMed ID: 23881551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effective Tyrosinase Inhibition by Thiamidol Results in Significant Improvement of Mild to Moderate Melasma.
    Arrowitz C; Schoelermann AM; Mann T; Jiang LI; Weber T; Kolbe L
    J Invest Dermatol; 2019 Aug; 139(8):1691-1698.e6. PubMed ID: 30825454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Melasma pathogenesis and influencing factors - an overview of the latest research.
    Passeron T
    J Eur Acad Dermatol Venereol; 2013 Jan; 27 Suppl 1():5-6. PubMed ID: 23205539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Future therapies in melasma: What lies ahead?
    Sarkar R; Bansal A; Ailawadi P
    Indian J Dermatol Venereol Leprol; 2020; 86(1):8-17. PubMed ID: 31793496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The first clinical experience on efficacy of topical flutamide on melasma compared with topical hydroquinone: a randomized clinical trial.
    Adalatkhah H; Sadeghi-Bazargani H
    Drug Des Devel Ther; 2015; 9():4219-25. PubMed ID: 26345129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melasma: insights and perspectives.
    Jadotte YT; Schwartz RA
    Acta Dermatovenerol Croat; 2010; 18(2):124-9. PubMed ID: 20624364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Newer and upcoming therapies for melasma.
    Sarkar R; Chugh S; Garg VK
    Indian J Dermatol Venereol Leprol; 2012; 78(4):417-28. PubMed ID: 22772611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Randomized, Controlled, Split-Face Study of the Efficacy of a Picosecond Laser in the Treatment of Melasma.
    Lyons AB; Moy RL; Herrmann JL
    J Drugs Dermatol; 2019 Nov; 18(11):1104-1107. PubMed ID: 31741350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of a novel picosecond laser using combination of 1 064 and 595 nm on patients with melasma: A prospective, randomized, multicenter, split-face, 2% hydroquinone cream-controlled clinical trial.
    Choi YJ; Nam JH; Kim JY; Min JH; Park KY; Ko EJ; Kim BJ; Kim WS
    Lasers Surg Med; 2017 Dec; 49(10):899-907. PubMed ID: 28906574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of combination of glycolic acid peeling with topical regimen in treatment of melasma.
    Chaudhary S; Dayal S
    J Drugs Dermatol; 2013 Oct; 12(10):1149-53. PubMed ID: 24085051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Energy-based device treatment of melasma: An update and review of the literature.
    Dunbar S; Posnick D; Bloom B; Elias C; Zito P; Goldberg DJ
    J Cosmet Laser Ther; 2017 Feb; 19(1):2-12. PubMed ID: 27594445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment of hydroquinone-resistant melasma using topical methimazole.
    Malek J; Chedraoui A; Nikolic D; Barouti N; Ghosn S; Abbas O
    Dermatol Ther; 2013; 26(1):69-72. PubMed ID: 23384022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melasma: treatment evaluation.
    Salem A; Gamil H; Ramadan A; Harras M; Amer A
    J Cosmet Laser Ther; 2009 Sep; 11(3):146-50. PubMed ID: 19340686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence-based Review, Grade of Recommendation, and Suggested Treatment Recommendations for Melasma.
    Sarma N; Chakraborty S; Poojary SA; Rathi S; Kumaran S; Nirmal B; Felicita J; Sarkar R; Jaiswal P; D'Souza P; Donthula N; Sethi S; Ailawadi P; Joseph B
    Indian Dermatol Online J; 2017; 8(6):406-442. PubMed ID: 29204385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.